Cellectar Biosciences, Inc. — Director's Dealing 2020

Dec 28, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2020-12-28

Reporting Person: CARUSO JAMES V (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-28	Common Stock	P	37037	$1.35	Acquired	81301	Direct